The National Clinical Evidence Taskforce delivered trusted, up-to-date clinical guidelines and flowcharts throughout the COVID-19 pandemic.
The Taskforce provided a world-leading model of ultra-rapid living guidelines, with daily evidence surveillance and broad cross-disciplinary collaboration, including healthcare professionals, evidence experts, consumers and peak health bodies across Australia. The guidelines were updated more than 130 times, and accessed by nearly a million users from across the world.
Funding was discontinued for the National Clinical Evidence Taskforce COVID-19 guidelines as of 30 June 2023. The guidelines were retired in 2026.
These guidelines are available for historical and research purposes only
External links have been removed to guard against invalidity. Links, files and other information may be available on request.
